Allergan wins brimonidine patent infringement case against Exela PharmSci & Apotex (PharmaBiz)
Allergan wins brimonidine patent infringement case against Exela PharmSci & Apotex (PharmaBiz)
Allergan, Inc announced that the United States District Court for the District of Delaware ruled in favour of Allergan, Inc in its patent infringement suit against Exela PharmSci, Inc, Exela PharmSci Pvt, Ltd, Apotex, Inc and Apotex Corp (collectively, the ‘Defendants’) for seeking to market purported generic versions of Allergan’s drugs Alphagan P (brimonidine tartrate ophthalmic solution) 0.1 …